These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 14718041

  • 1. Effects of steroids on oxytocin secretion by the human prostate in vitro.
    Assinder SJ, Nicholson HD.
    Int J Androl; 2004 Feb; 27(1):12-8. PubMed ID: 14718041
    [Abstract] [Full Text] [Related]

  • 2. Evidence for the regulation of prostatic oxytocin by gonadal steroids in the rat.
    Jenkin L, Nicholson HD.
    J Androl; 1999 Feb; 20(1):80-7. PubMed ID: 10100477
    [Abstract] [Full Text] [Related]

  • 3. Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
    de Jong FH, Reuvers PJ, Bolt-de Vries J, Mulder E, Blom JH, Schroeder FH.
    J Steroid Biochem Mol Biol; 1992 Mar; 42(1):49-55. PubMed ID: 1373073
    [Abstract] [Full Text] [Related]

  • 4. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R, Puah CM.
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK, Ross M, Tate R, Chisholm GD.
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P, Sánchez C, Contreras HR, Vergara J, Acevedo C, Cabezas J, Huidobro C, Noé G, Castellón EA.
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [Abstract] [Full Text] [Related]

  • 11. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate.
    Whittington K, Connors B, King K, Assinder S, Hogarth K, Nicholson H.
    Prostate; 2007 Jul 01; 67(10):1132-42. PubMed ID: 17492653
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effects of antiandrogen TZP-4238 on the prostatic androgen receptor and prostatic androgen in rat].
    Honma S, Suzuki K, Takezawa Y, Minato K, Fukabori Y, Yamanaka H.
    Nihon Naibunpi Gakkai Zasshi; 1994 Oct 20; 70(8):925-40. PubMed ID: 7528148
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Androgen dynamics in vitro in the human prostate gland. Effect of cyproterone and cyproterone acetate.
    Giorgi EP, Shirley IM, Grant JK, Stewart JC.
    Biochem J; 1973 Mar 20; 132(3):465-74. PubMed ID: 4125095
    [Abstract] [Full Text] [Related]

  • 20. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
    Di Silverio F, Monti S, Sciarra A, Varasano PA, Martini C, Lanzara S, D'Eramo G, Di Nicola S, Toscano V.
    Prostate; 1998 Oct 01; 37(2):77-83. PubMed ID: 9759701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.